Health Matters
  • Home
  • About
  • News
    • Top Stories
    • Recent News
    • Archive
  • Subscription
  • My Account
    • My profile
    • Corporate Profile
    • Cancel
  • Orders
  • Login
  • Contact
  • Billing
  • Contact
Select Page
Imported Medicines Threaten SA’s Local Pharmaceutical Industry

Imported Medicines Threaten SA’s Local Pharmaceutical Industry

by Tamar Kahn | Business Day | 9 June 2026 | Jun 11, 2026 | June 2026, Recent News

Learn how reliance on imported medicines threatens South Africa's jobs and the industry's pharmaceutical security.

Subscription Required

You must be a subscriber to access all of this content.

View Subscriptions

Already a subscriber? Log in here
Surge in Malaria as Climate Change Fuels Regional Outbreaks

Surge in Malaria as Climate Change Fuels Regional Outbreaks

by The Citizen | 9 June 2026 | Jun 11, 2026 | June 2026, Recent News

Malaria cases surge despite efforts to eliminate the disease. Discover the impact of weather conditions on this worrying trend.

Subscription Required

You must be a subscriber to access all of this content.

View Subscriptions

Already a subscriber? Log in here
Lenacapavir HIV Prevention Injection: SA Rollout Faces Heat

Lenacapavir HIV Prevention Injection: SA Rollout Faces Heat

by Tamar Kahn | Business Day | 5 June 2026 | Jun 10, 2026 | June 2026, Recent News

The lenacapavir HIV Prevention Injection rollout begins in SA, but activists warn that limited supply from Gilead could blunt the impact.

Subscription Required

You must be a subscriber to access all of this content.

View Subscriptions

Already a subscriber? Log in here

Daraxonrasib Pancreatic Cancer Pill Doubles Survival

by Andrew Gregory | The Guardian | 4 May 2026 | Jun 9, 2026 | Archive, June 2026

Daraxonrasib Pancreatic Cancer Pill nearly doubled survival in metastatic PDAC, beating second-line chemo with fewer discontinuations.

Subscription Required

You must be a subscriber to access all of this content.

View Subscriptions

Already a subscriber? Log in here

Medical Scheme Financial Pressure Escalates As Costs Soar

by Tamar Kahn | Business Day | 4 June 2026 | Jun 9, 2026 | Archive, June 2026

Medical scheme financial pressure intensifies as healthcare costs, an ageing population, and a R11.64bn operating deficit squeeze the sector.

Subscription Required

You must be a subscriber to access all of this content.

View Subscriptions

Already a subscriber? Log in here
« Older Entries
Next Entries »

Recent Posts

  • Slow Patent Reform Delays Access to Medicines
  • SA’s Ebola Preparedness Rises As DRC Outbreak Grows
  • Primary Healthcare Accountability Under Scrutiny In Johannesburg
  • Reach For A Dream Anniversary Highlights Power Of Hope
  • Public Health System Shows Signs of Progress

Recent Comments

No comments to show.

Archives

  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024

Categories

  • April 2025
  • April 2026
  • Archive
  • August 2024
  • August 2025
  • December 2025
  • February 2025
  • February 2026
  • Free
  • January 2026
  • July 2024
  • July 2025
  • July 2026
  • June 2024
  • June 2025
  • June 2026
  • March 2025
  • March 2026
  • May 2025
  • May 2026
  • News
  • November 2024
  • November 2025
  • October 2024
  • October 2025
  • Recent News
  • September 2024
  • September 2025
  • Uncategorized

Designed by Elegant Themes | Powered by WordPress